Q3 2020 Vascular Biogenics Ltd Earnings Call Transcript
Greetings. Welcome to VBL Therapeutics Third Quarter 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded. I would now like to turn over conference to your host, Michael Wood with LifeSci Advisors. Thank you. You may begin.
Thank you, operator. Good morning, and thank you all for participating in today's third quarter 2020 results and corporate update for VBL Therapeutics. Leading the call this morning will be Professor Dror Harats, CEO of VBL; and Amos Ron, the company's CFO. A press release with the company's financial results became available earlier this morning and can be found on the Investors page of the company's website at vblrx.com.
Before we begin, I'd like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. VBL cautions that these forward-looking statements are the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |